Filing metadata

Accession number
0001610717-24-000232
Form type
Form 4
Filer
Corvus Pharmaceuticals, Inc.
CIK
CIK 1626971
Filed
May 07, 2024
Reporting period
May 06, 2024
Description
Insider transaction

Explore SEC Filings Hub